Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Study suggests Alzheimer’s Disease and Type 2 diabetes might both be the price of a longer lifespan, with altered insulin function the common cause.

Image courtesy of Shutterstock

A review led by Professor Simon Lovestone, an old age psychiatrist from Oxford Health NHS Foundation Trust, found that humans were almost unique in having Alzheimer’s Disease. This is the first study to find unambiguous signs of the disease in a wild animal.

'It is very rare to find signs of full-blown Alzheimer’s Disease in non-human brains,' said Professor Lovestone, who is also researcher within the Oxford University Department of Psychiatry and the dementia theme lead for the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC). ‘This is the first time anyone has found such clear evidence of the protein plaques and tangles associated with Alzheimer’s Disease in the brain of a wild animal.’

Read more

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.